Five Prime Therapeutics (FPRX) Misses Q3 EPS by 30c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. EXPE
3. ARM
4. FIS
5. BROS
6. DDOG
7. QCOM
8. ZG
9. EW
10. CPAY

Go back to Five Prime Therapeutics (FPRX) Misses Q3 EPS by 30c

Five Prime Therapeutics (FPRX) Comments From Jefferies 'Data Not As Strong As We Like To See'

November 7, 2017 11:51 AM EST

Jefferies maintains Buy on Five Prime Therapeutics (NASDAQ: FPRX) price target of $52.00.

Analyst Eun Yang says the high rates of cabira-associated SAEs are concerning and chooses to await full data presentation at SITC on this coming SAturday before revisiting the... More

Five Prime Therapeutics (FPRX) Selloff Unfounded - Nomura/Instinet

November 7, 2017 11:14 AM EST

Nomura/Instinet maintains Buy on Five Prime Therapeutics (NASDAQ: FPRX) price target of $94.00.

Analyst Chris Marai defends the name noting durable IP activity is evident. The analyst reminds clients that cabria is also mechanistically more likely to price benefit to pancreatic patients in... More